Bushido Capital US Equity ETF Rating $47.55 -0.12 (-0.25%) As of 08/14/2026 03:35 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestTrendsBuy This Stock Bushido Capital US Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SMRI Aggregate RatingModerate Buy 2.51Holdings in SMRI have an aggregate rating of Moderate Buy based on 620 analyst ratings issued in the past year covering 25 companies (55.9% of the portfolio).SMRI Aggregate Price Target$47.55High Prediction$47.55Average Prediction$47.55Low Prediction$47.55Holdings in SMRI have an aggregate price target of $47.55 and a range of $47.55 to $47.55 covering 25 companies (55.9% of the portfolio).SMRI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Bushido Capital US Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SMRI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.74%WDAYWorkday$198.68-3.8%3.3145 of 5 stars2.54$187.36 -5.7%37Trending NewsAnalyst Forecast2.57%THCTenet Healthcare$267.23+0.1%3.1355 of 5 stars2.95$273.00 2.2%21Analyst UpgradeAnalyst Revision2.56%VEEVVeeva Systems$243.60-3.6%3.4148 of 5 stars2.68$247.08 1.4%28Analyst Upgrade2.45%ACNAccenture$176.60-1.1%4.5811 of 5 stars2.41$192.96 9.3%272.37%ADBEAdobe$264.02-2.4%4.4754 of 5 stars2.06$269.81 2.2%33Trending News2.31%LDOSLeidos$143.89+0.9%4.5785 of 5 stars2.47$160.27 11.4%17Analyst ForecastInsider Trade2.27%ABNBAirbnb$184.06-0.6%4.2258 of 5 stars2.64$172.00 -6.6%39Trending NewsAnalyst DowngradeInsider Trade2.27%EXPEExpedia Group$332.69+1.3%4.5629 of 5 stars2.44$311.76 -6.3%39Analyst ForecastInsider Trade2.23%INTUIntuit$345.66-3.5%4.9961 of 5 stars2.50$456.90 32.2%32Trending NewsAnalyst Forecast2.23%BKNGBooking$212.06-0.6%4.543 of 5 stars2.81$235.72 11.2%36News CoveragePositive NewsInsider Trade2.22%GENGen Digital$28.48-3.7%4.5331 of 5 stars2.33$31.67 11.2%9Insider TradeOptions Volume2.21%CRMSalesforce$195.86-2.7%4.8937 of 5 stars2.55$249.05 27.2%47Trending NewsAnalyst ForecastShort Interest Decrease2.18%ADPAutomatic Data Processing$272.96-1.2%4.3924 of 5 stars2.15$273.50 0.2%13Positive News2.16%PAYXPaychex$122.02-2.7%2.1223 of 5 stars2.00$109.20 -10.5%17Positive NewsAnalyst Forecast2.16%REGNRegeneron Pharmaceuticals$803.48-0.3%3.775 of 5 stars2.62$793.74 -1.2%26Trending NewsAnalyst UpgradeInsider Trade2.16%ROPRoper Technologies$399.34+0.5%4.3569 of 5 stars2.16$466.94 16.9%19Positive News2.15%ZMZoom Communications$105.96-3.5%3.0852 of 5 stars2.56$109.33 3.2%27Positive NewsInsider Trade2.15%VLOValero Energy$341.36-0.5%4.4877 of 5 stars2.67$288.00 -15.6%21Positive NewsAnalyst Revision2.12%NTAPNetApp$207.08+1.0%3.2181 of 5 stars2.33$172.33 -16.8%15Insider Trade2.12%MPCMarathon Petroleum$355.61-0.2%3.9006 of 5 stars2.67$312.50 -12.1%18Analyst ForecastOptions Volume2.11%PSXPhillips 66$233.29+0.3%4.5953 of 5 stars2.68$206.56 -11.5%22Trending NewsAnalyst UpgradeInsider Trade2.07%OMCOmnicom Group$87.45-1.0%4.3077 of 5 stars2.18$99.00 13.2%11Positive News2.05%NEMNewmont$117.80+3.2%4.6939 of 5 stars2.92$132.59 12.6%24Trending NewsAnalyst ForecastOptions Volume2.03%INCYIncyte$120.16-0.3%3.5255 of 5 stars2.43$120.65 0.4%23Positive NewsAnalyst Forecast1.99%JAZZJazz Pharmaceuticals$244.96-0.4%4.0586 of 5 stars2.95$272.89 11.4%20Analyst Forecast This page (NASDAQ:SMRI) was last updated on 8/15/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bushido Capital US Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Bushido Capital US Equity ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMRI Stock Alerts